NGM Biopharmaceuticals Price on July 24, 2023

NGMDelisted Stock  USD 2.50  0.14  5.30%   
If you're considering investing in NGM Stock, it is important to understand the factors that can impact its price. As of today, the current price of NGM Biopharmaceutica stands at 2.50, as last reported on the 25th of November, with the highest price reaching 2.64 and the lowest price hitting 2.49 during the day. We have found twenty-four technical indicators for NGM Biopharmaceutica, which you can use to evaluate the volatility of the firm. Please verify NGM Biopharmaceutica's risk adjusted performance of (0.08), and Mean Deviation of 3.76 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
NGM Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NGM
Based on monthly moving average NGM Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NGM Biopharmaceutica by adding NGM Biopharmaceutica to a well-diversified portfolio.

Related Headline

Kezar Life Headline on 24th of July 2023

Filed transaction by Kezar Life Sciences Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

NGM Biopharmaceutica Valuation on July 24, 2023

It is possible to determine the worth of NGM Biopharmaceutica on a given historical date. On July 24, 2023 NGM was worth 2.64 at the beginning of the trading date compared to the closed value of 2.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NGM Biopharmaceutica stock. Still, in general, we apply an absolute valuation method to find NGM Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NGM Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NGM Biopharmaceutica's related companies.
 Open High Low Close Volume
  2.78    2.78    2.59    2.60    137,500  
07/24/2023
  2.64    2.64    2.49    2.50    137,119  
  2.64    2.64    2.49    2.50    0.00  
Backtest NGM Biopharmaceutica  |  NGM Biopharmaceutica History  |  NGM Biopharmaceutica Valuation   PreviousNext  
Open Value
2.64
2.5
Closing Value
2.64
Upside

NGM Biopharmaceutica Trading Date Momentum on July 24, 2023

On November 25 2024 NGM Biopharmaceuticals was traded for  2.50  at the closing time. Highest NGM Biopharmaceutica's price during the trading hours was 2.64  and the lowest price during the day was  2.49 . There was no trading activity during the period 0.0. Lack of trading volume on the 25th of November did not cause price change. The trading delta at closing time to current price is 5.60% .

NGM Biopharmaceuticals Fundamentals Correlations and Trends

By evaluating NGM Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NGM Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NGM financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About NGM Biopharmaceutica Stock history

NGM Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NGM is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NGM Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NGM Biopharmaceutica stock prices may prove useful in developing a viable investing in NGM Biopharmaceutica
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California. Ngm Biopharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people.

NGM Biopharmaceutica Stock Technical Analysis

NGM Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of NGM Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NGM Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

NGM Biopharmaceutica Period Price Range

Low
November 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

NGM Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

NGM Biopharmaceutica November 25, 2024 Market Strength

Market strength indicators help investors to evaluate how NGM Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NGM Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying NGM Biopharmaceutica stock market strength indicators, traders can identify NGM Biopharmaceuticals entry and exit signals to maximize returns

NGM Biopharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NGM Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of NGM Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NGM to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Consideration for investing in NGM Stock

If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine